Precision Medicine Market to Reach USD 103.73 Billion by 2035 with 11.3% CAGR Driven by Genomic Sequencing and AI Integration

The precision medicine market is projected to reach a valuation of USD 103.73 billion by 2035, growing at a compound annual growth rate (CAGR) of 11.3%, according to recent industry analysis. Key drivers of this growth include advancements in genomic sequencing, the increasing use of companion diagnostics, and the rising demand for personalized treatment approaches. The integration of artificial intelligence (AI) into healthcare systems and the development of targeted therapies are also contributing significantly to the expansion of this sector.

The report highlights that genomic sequencing technologies are playing a pivotal role in enabling tailored medical treatments based on individual genetic profiles. Companion diagnostics, which help identify suitable therapies for specific patients, are gaining traction as part of this trend toward personalized care. Additionally, AI-driven tools are being increasingly utilized to analyze complex datasets and improve decision-making in clinical settings. These developments align with broader efforts to enhance treatment efficacy and reduce adverse effects through more precise interventions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: September 11, 2025

Related posts:

Novel Method Combines Heart Biopsy and Device Implantation to Reduce Risk of Complications DrugPatentWatch: Strong Product Pipeline and Patent Portfolio Drive Pharmaceutical Company Valuation Paysign Reports Millions Saved Through Data-Driven Analysis of First-Fill Prescriptions to Address Copay Maximizer Challenges Combination of Two Experimental Drugs Shows Promise in Inhibiting Tumor Growth and Resistance in Preclinical Ovarian Cancer Study

Author

Mark Chiang